Taking peopleNo phase
Vercise™ DBS Dystonia Prospective Study
Key facts
- Who runs it
- Boston Scientific Corporation
- Where
- Jerusalem, IsraelSee the siteAlso in 11 other countries, 35 sites
- Trial code
- Status
- Recruiting
- People taking part
- 300 people, planned
- Started
- 7 Mar 2016
- Expected to end
- Dec 2030
- Type of study
- Observational
- Treatments tested
- Deep Brain Stimulation (DBS)
- Record updated
- 13 October 2026
Who can take part
- Age
- 7 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 3 criteriaShow less
Who can take part
- IC1. Meets criteria established in the locally applicable Vercise System Directions for Use (DFU) for dystonia
- IC2. At least 7 years old. Parent or guardian consent is required in patients who are younger than 18 years at the time of consent
Who cannot take part
- EC1. Meets any contraindication in the Vercise System locally applicable Directions for Use
Where in Israel
Also in 11 other countries, 35 sites
- Hadassah Hebrew University Medical CenterJerusalem, IsraelContact: Stephanie DelvauxNo longer taking part
About the trial
What the trial wants to find out
To compile characteristics of real-world outcomes of Boston Scientific Corporation's commercially approved VerciseTM Deep Brain Stimulation (DBS) Systems for the treatment of dystonia.
Treatments tested
- Deep Brain Stimulation (DBS)
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Prospective Study of Deep Brain Stimulation With the VERCISE™ System for Treatment of Dystonia
- Record updated
- 13 October 2026